文献速递前列腺癌

局限前列腺癌根治术与放疗结局比较:纵向人群分析

The Comparative Outcomes of Radical Prostatectomy versus Radiotherapy for Nonmetastatic Prostate Cancer: A Longitudinal, Population-Based Analysis.
PubMed 文献 · J Urol · 2020-02-18

该研究基于加拿大曼尼托巴省2004-2016年链接行政数据集,纳入2540例根治性前列腺切除术(RP)和1895例放疗(RT)的非转移性前列腺癌患者。采用逆概率治疗加权Cox回归分析,结果显示RT组全因死亡率(HR 1.93,95%CI 1.65-2.26,p<0.0001)和前列腺癌特异性死亡率(HR 3.98,95%CI 2.89-5.49,p<0.0001)均显著高于RP组。

要点

  • 在平等可及医疗体系中,RP组全因死亡和前列腺癌特异性死亡风险低于RT组。
  • 5年总生存率RP组95.52%,RT组84.55%(p<0.0001),但未校正混杂。
  • 逆概率加权后RT组全因死亡风险为RP组1.93倍,前列腺癌特异性死亡风险为3.98倍。

核心结论

  • 与根治性前列腺切除术相比,放疗与更高的全因死亡率和前列腺癌特异性死亡率相关。

研究设计与样本

  • 回顾性队列研究,链接加拿大曼尼托巴省多个行政数据集,纳入2004-2016年诊断为非转移性前列腺癌并接受RP或RT的患者,共2540例RP和1895例RT。

主要发现

  • 未校正5年总生存率RP组95.52%,RT组84.55%(p<0.0001)。
  • 逆概率治疗加权Cox回归显示RT组全因死亡率高于RP组(HR 1.93,95%CI 1.65-2.26,p<0.0001)。
  • RT组前列腺癌特异性死亡率高于RP组(HR 3.98,95%CI 2.89-5.49,p<0.0001)。

临床怎么用

  • 在平等可及医疗体系中,非转移性前列腺癌患者选择RP或RT时,应告知RT与更高的全因死亡和前列腺癌特异性死亡风险相关。

局限性

  • 回顾性研究设计,尽管采用逆概率治疗加权,仍可能存在未测量混杂。
  • 基于行政数据,缺乏详细临床分期、分级和治疗方案信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The comparative effectiveness of radical prostatectomy (RP) versus radiation therapy (RT) for prostate cancer remains a largely debated topic. Utilizing a provincial population-based linked data set from an equal-access, universal health care system, we sought to compare outcomes among patients treated with either radiation or prostatectomy for nonmetastatic prostate cancer. MATERIALS AND METHODS: We performed a retrospective cohort study by linking several administrative data sets to identify patients who were diagnosed with prostate cancer between 2004 and 2016 in Manitoba, Canada and who were subsequently treated with either RP or RT. Cox proportional hazard models with inverse probability of treatment weighting were used to compare rates of all-cause mortality, as well as prostate cancer specific mortality (PCSM) between patients who underwent RP vs RT. RESULTS: During the study period, 2,540 patients underwent RP and 1,895 underwent RT for prostate cancer. Unadjusted overall survival was higher for RP vs RT (5-year overall survival 95.52% for RP compared with 84.55% for RT, p <0.0001). In inverse probability of treatment weighting-adjusted Cox regression analysis, compared to patients in the RP groups, patients in the RT group had an increased rate of all-cause mortality (HR 1.93, 95% CI 1.65-2.26, p <0.0001), and PCSM (HR 3.98, 95% CI 2.89-5.49; p <0.0001). CONCLUSIONS: RT was associated with higher all-cause mortality and PCSM rates compared with RP. These findings highlight the importance of comparative effectiveness research to identify treatment disparities and warrant further investigation.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Oake JD, Shiff B, Harasemiw O, et al. The Comparative Outcomes of Radical Prostatectomy versus Radiotherapy for Nonmetastatic Prostate Cancer: A Longitudinal, Population-Based Analysis. J Urol. 2020. PMID: 32068493. doi:10.1097/JU.0000000000000805

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。